MAY 15, 2021 9:30 AM PDT

New Drug Blocks Critical Step in Malaria Life Cycle

WRITTEN BY: Annie Lennon

According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around the world, of which 409,000 were fatal. Now, researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a compound that blocks a crucial step in the malaria parasite life cycle. 

Malaria is caused by a single-celled parasite that invades and replicates inside of red blood cells. Once it has replicated many times, it bursts out into the bloodstream to repeat the process. It is this cycle of invading and bursting out of red blood cells that causes symptoms and sometimes fatal effects of the disease. 

Whereas existing drugs for malaria work by killing the parasite while inside red blood cells, this new drug works by blocking the parasite from being able to burst out of them, thus halting the progression of the disease. In particular, the drug works by blocking an enzyme known as SUB1, which is crucial for malaria parasites to burst out of red blood cells. So far, the researchers have found that the compound is effective in human cell tests. 

As current strains of malaria have started to develop resistance to existing antimalarial drugs, the researchers hope that this new drug will one day be able to work in lieu of them. Until then, however, they acknowledge that further research is needed- in particular, to make the new compound smaller and more potent. Once this has happened, further experiments on animals and then humans will be needed to show that it is both safe and effective. 

"Many existing antimalarialplant-derivedant derived and while they're incredibly effective, we don't know the precise mechanisms behind how they work.” says Chrislaine Withers-Martinez, one of the authors of the study.

“Our decades of research have helped us identify and understand pathways crucial to the malaria life cycle allowing us to rationally design new drug compounds based on the structure and mechanism of critical enzymes like SUB1. This approach, which has already been highly successful at finding new treatments for diseases including HIV and Hepatitis C, could be key to sustained and effective malaria control for many years to come."

 

Sources: News Medical Life SciencesPNAS

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
JUL 25, 2022
Cardiology
Drug that Can Help Men Live Longer?
JUL 25, 2022
Drug that Can Help Men Live Longer?
A new study from the University of Virginia School of Medicine and recently published in Science discusses how the loss ...
JUL 23, 2022
Drug Discovery & Development
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
JUL 23, 2022
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
An anti-inflammatory compound has shown promise in treating systemic inflammation and brain injury in patients with seve ...
AUG 07, 2022
Neuroscience
Physiotherapy Technique Significantly Improves Chronic Back Pain
AUG 07, 2022
Physiotherapy Technique Significantly Improves Chronic Back Pain
Sensorimotor retraining significantly improves pain intensity in chronic low back pain. The corresponding study was publ ...
SEP 11, 2022
Microbiology
Using Yeast Cells to Make a Cancer Treatment
SEP 11, 2022
Using Yeast Cells to Make a Cancer Treatment
Vinblastine and vincristine are both common chemotherapies that are used to treat several types of cancer. The drugs sto ...
SEP 08, 2022
Drug Discovery & Development
Tired of Long COVID? A new drug shows promise to combat fatigue caused by long COVID
SEP 08, 2022
Tired of Long COVID? A new drug shows promise to combat fatigue caused by long COVID
If you are reading this, chances are you have had COVID; unless you are one of the few “super dodgers” ...
Loading Comments...